Feed/Companies/Aspect Biosystems

Aspect Biosystems

As of 14 Oct 2026, Aspect Biosystems has raised $115M across 1 verified round on record; latest: US$115 million Series B led by Dimension, announced 8 Jan 2025.

BUILT ON

Visit site

Bioengineered cellular medicines aimed at transforming disease treatment using bioprinting technology and regenerative medicine.

aspectbiosystems.comLinkedInVancouver, BC, CanadaBiotech

LATEST ROUND

Series B

$115M · 2025-01-08

RAISED ON RECORD · USD

$115M

across 1 verified round

INVESTORS

1 lead

SOURCES

from 2 publishers

Feed/Companies

Company

Every round on record, with the sources behind each and the investors on them.

BUILT ON

Series BSeries B financing round

$115M · 2025-01-08

[ HISTORY ]

led by Dimension

Round	Amount	Announced	Lead	Buzz
Series B Series B financing round [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$115M	2025-01-08	Dimension	No recent discussion
2 sources [ VERIFIED ] read against 2 sources Business Wire lists a publication date of 2025-01-14, but the company's release and the release dateline state January 8, 2025; January 8 is used.

Aspect Biosystems

Company

Rounds

Sources

Profile

Investors

Aspect Biosystems

Rounds

Profile

Sources

Series B$115M2025-01-082 sources

Investors

Series B$115M2025-01-088 investors